About Me

I’m Brice Dreamer — a pharmaceutical engineering consultant and founder who helps ambitious teams translate big investments into measurable impact. My career has spanned capital program leadership, operating model design, and AI-powered product building for highly regulated environments.

Today I split my time between Dreamer Studios, where I advise global pharma companies on portfolio strategy and transformation, and Ravel Trips, a venture making bespoke travel planning more collaborative, transparent, and human. I thrive at the intersection of rigorous systems thinking and imaginative storytelling.

Outside of work, you’ll find me spending time with my two kids, playing reggae metal with my band, and experimenting with ways generative AI can empower teams. If you’re building something ambitious — in pharma, travel, or beyond — let’s talk.

Experience snapshot

Dreamer Studios · Basel, Switzerland

President & Consultant

April 2023 – Present

Advise global pharma organizations on program management, investment strategy, and AI-enabled transformation.
Led the initial design phase for a $2B plasma facility, coordinating scenario analyses across multiple alternatives.
Directed a network-wide modernization program for aseptic filling, guiding roadmap, governance, and capital approvals.
Architected benchmarking tooling for rapid investment assessments and developed operating models for new API capacity.
Prototyped a generative AI SaaS product to accelerate technical and procedural documentation workflows.

Ravel Travel Inc. · Phoenix, Arizona & Switzerland

Cofounder & CEO

April 2022 – Present

Built a collaborative trip-planning marketplace connecting travelers with expert planners worldwide.
Launched AI-powered itinerary generation that transforms social inspiration into bookable journeys.
Scaled a distributed team of eight, secured funding, and achieved profitability while expanding the product toolkit.

Novartis AG · Basel, New York, and Global

Various Strategy, Engineering & Operations Leadership

2010 – April 2022

Managed multi-billion dollar capex portfolios for Cell & Gene therapies and capex project management
Chaired global investment committees, integrating new technology platforms and external manufacturing partnerships.
Championed manufacturing strategy initiatives, including high-density perfusion culture and continuous manufacturing.
Led compliance, quality, and engineering programs across chemical, biotech, and solid dosage operations in Europe and the US.
Developed enterprise business cases, site selection studies, and process excellence frameworks adopted across Novartis.

Education

2016
Master of Business Administration (MBA)
University of St. Gallen (HSG), Switzerland
2010
Bachelor of Science, Mechanical Engineering
Bucknell University, Pennsylvania, USA